Biopharmaceutical company Kitov received FDA 510(k) clearance for its Consensi oral tablets for the treatment of osteoarthritis pain and hypertension.
Here are three things to know:
1. Consensi is a patent-protected combination of the non-steroidal anti-inflammatory drug celecoxib and amlodipine besylate, an antihypertensive calcium channel blocker.
2. It is indicated for patients for whom amlodipine treatment for hypertension and celecoxib treatment for osteoarthritis are appropriate.
3. According to Kitov's founder and CMO J. Paul Waymack, MD, the company will now focus on NT219, an investigational new drug candidate currently in development for several oncology indications.
More articles on orthopedics:
Dr. Leslie Dean retires: 3 things to know
Orthopedic surgeon to know: Dr. James Carson of Cypress Fairbanks Medical Center Hospital
Drs. Paul Pellici, Craig Miller & more: 4 orthopedic surgeons making headlines